-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cavrotolimod in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cavrotolimod in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cavrotolimod in Hepatitis B Drug Details: Cavrotolimod (AST-008) is under development for...
-
Sector Analysis
Lebanon Insurance Industry – Key Trends and Opportunities to 2028
Lebanon Insurance Market Report Overview The gross written premium of the Lebanon insurance market was LBP5.1 trillion ($81.5 million) in 2023. The market is expected to achieve a CAGR of more than 42% during 2024-2028. The Lebanon insurance market research report provides a detailed outlook by product category for the Lebanon insurance industry. Lebanon Insurance Market Outlook, 2023-2028 (LBP Trillion) Buy the Full Report for More Insights into the Lebanon Insurance Market Forecast Download a Free Report Sample The Lebanon...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PEG-irinotecan in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PEG-irinotecan in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PEG-irinotecan in Metastatic Breast Cancer Drug Details: PEG-Irinotecan is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SNA-11 in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SNA-11 in Treatment Resistant Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SNA-11 in Treatment Resistant Depression Drug Details:SNA-11 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ascorbic Acid in Bronchiectasis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ascorbic Acid in Bronchiectasis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ascorbic Acid in Bronchiectasis Drug Details: Ascorbic acid is under development for...
-
Company Profile
Exicure Inc – Company Profile
Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC is a pharmaceutical company that discovers, develops and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid constructs. The company’s technology portfolio comprises SNA gene regulation platform and genetic analysis tools. Exicure's pipeline spans SNA based therapeutics for the treatment of psoriasis, fibrosis, diabetic ulcers, bladder cancer, and inflammation; AST008, SCN9A, CLN3, TLR9 agonist and allergan. Its SNA’s are also used as immunotherapeutic agents for the treatment of cancer and...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – SNA-11
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry SNA-11 Drug Details SNA-11 is under development for the treatment of treatment resistant depression....
-
Sector Analysis
Personal Accident and Health Insurance in Lebanon, Key Trends and Opportunities to 2020
GlobalData’s 'Personal Accident and Health Insurance in Lebanon, Key Trends and Opportunities to 2020' report provides in-depth market analysis, information and insights into the Lebanese personal accident and health insurance segment, including: • An overview of the Lebanese personal accident and health insurance segment • The Lebanese personal accident and health insurance segment’s growth prospects by category • A comprehensive overview of the Lebanese economy and demographics • A comparison of the Lebanese personal accident and health insurance segment with...
-
Track & Monitor
Tobacco Insights 2016 – September
“Tobacco Insights”, is a monthly report by Canadean which provides extensive and highly detailed information on the changing production and consumption patterns affected by the recent developments related to new laws and regulations globally